MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-GJ-01-0000950
Swefn Pharmaceuticals Private Limited - pharma in Moraiya, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹66.63 Cr
▲ 9% YoY
Net profit · FY 2025
₹2 Cr
Net margin 3%
EBITDA · FY 2025
₹4.57 Cr
EBITDA margin 6.9%
Authorised capital
₹3.3 Cr
Registered with MCA
Paid-up capital
₹3.3 Cr
Issued & subscribed
Open charges
₹7.45 Cr
Secured borrowings
Company age
9 yrs
Est. 2017
Employees · EPFO
34
Provident fund records
About Swefn Pharmaceuticals Private Limited
Data last updated:
Swefn Pharmaceuticals Private Limited is a private limited company based in Moraiya, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 September 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24110GJ2017PTC099133. Its GSTIN is 24AAZCS2385Q1Z8 (Gujarat).
The company has an authorised share capital of ₹3.3 Cr and a paid-up capital of ₹3.3 Cr. It is led by directors including Dhavalkumar Himmatbhai Satashia and Niharbhai Sureshbhai Satasiya.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at S. No. 359 Plot No:7 Sopan Kesar Industrial Hub Moraiya Vill:Moraiya Tal Sanand Dist., :Ahmadabad, Gujarat, India – 382213.
As per the financials filed for FY 2025, the company reported a revenue of ₹66.63 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹2 Cr (net margin 3%) and EBITDA of ₹4.57 Cr (EBITDA margin 6.9%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 59% over five years.
The company has about 34 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: SWEFN Pharmaceutical. As per MCA filings, the company has open charges of ₹7.45 Cr on record. Court records list 1 case involving the company, including 1 filed against it. The company has 1 deal on record (1 secondary share transfer); the latest was in February 2018. Its 7 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 4 smaller; the largest is Premium Serums and Vaccines Private Limited with revenue of ₹67.25 Cr.
Swefn Pharmaceuticals Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0000950). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website swefnpharma.com.
Company details
CIN U24110GJ2017PTC099133
Registration Number 099133
Incorporation Date 18 September 2017
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-GJ-01-0000950
Key People
Dhavalkumar Himmatbhai Satashia Director Niharbhai Sureshbhai Satasiya Director Keval Kishorbhai Satasiya Director Recognitions & Rankings of Swefn Pharmaceuticals
Contact details
Swefn Pharmaceuticals Private Limited's registered office is in Moraiya, Gujarat. Its website is swefnpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressS. No. 359 Plot No:7 Sopan Kesar Industrial Hub Moraiya Vill:Moraiya Tal Sanand Dist., :Ahmadabad, Gujarat, India – 382213
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Swefn Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Swefn Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Swefn Pharmaceuticals operates one associated brand: SWEFN Pharmaceutical. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Operates as a research-based pharmaceutical manufacturer. | swefnpharma.com |
Business activity
The main business activity of Swefn Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Swefn Pharmaceuticals Private Limited, buy the company report.
Financials of Swefn Pharmaceuticals Private Limited
FY 2025 filings availableSwefn Pharmaceuticals Private Limited reported revenue of ₹66.63 Cr (up 9% YoY) for FY 2025.
Revenue · FY 2025
₹66.63 Cr ▲ 9%
Net profit · FY 2025
₹2 Cr margin 3%
EBITDA · FY 2025
₹4.57 Cr margin 6.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 9%
3 years · compounded
▲ 7%
5 years · compounded
▲ 59%
EBITDA CAGR growth
1 year
▲ 15%
3 years · compounded
▲ 20%
5 years · compounded
▲ 51%
Revenue has grown at a compounded annual rate (CAGR) of 59% over five years, including 9% growth in the latest year. EBITDA rose 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.57 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.9% | ||||
| Net Profit Margin | 3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Swefn Pharmaceuticals Private Limited, buy the company report.
Board of directors of Swefn Pharmaceuticals Private Limited
Swefn Pharmaceuticals has 6 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dhavalkumar Himmatbhai Satashia | Director | 18 Sep 2017 | 9 Years 1 Months | Current |
| Niharbhai Sureshbhai Satasiya | Director | 18 Sep 2017 | 9 Years 1 Months | Current |
| Keval Kishorbhai Satasiya | Director | 12 Feb 2018 | 8 Years 8 Months | Current |
| Nikunj Dineshbhai Satasiya | Director | 12 Feb 2018 | 8 Years 8 Months | Current |
| Dharmesbhai Babubhai Satashia | Director | 24 Apr 2023 | 3 Years 6 Months | Current |
| Vitul Mahendrabhai Patel | Director | 24 Apr 2023 | 3 Years 6 Months | Current |
Peer comparison
Swefn Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Premium Serums and Vaccines Private Limited | ₹67.25 Cr (FY 2025) | 28.0% | Mumbai, Maharashtra, India | |||
| Africure Pharmaceuticals (India) Private Limited | ₹66.93 Cr (FY 2025) | 1.0% | Palghar, Maharashtra, India | |||
| Pharmax India Private Limited | ₹66.65 Cr (FY 2024) | 2.0% | Mumbai, Maharashtra, India | |||
| Swefn Pharmaceuticals Private Limitedthis company | ₹66.63 Cr (FY 2025) | ₹2 Cr | 3% | 9.0% | 35 | Moraiya, Gujarat, India |
| Merril Pharma Private Limited | ₹66.57 Cr (FY 2025) | 25.0% | Ahmedabad, Gujarat, India | |||
| Hiral Labs Limited | ₹66.46 Cr (FY 2025) | 6.0% | Ahmedabad, Gujarat, India | |||
| Skyec Drugs and Pharmaceuticals Private Limited | ₹66.27 Cr (FY 2025) | 19.0% | Chennai, Tamil Nadu, India | |||
| Medizen Labs Private Limited | ₹66.2 Cr (FY 2023) | 39.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Swefn Pharmaceuticals Private Limited, buy the company report.
Auditor
Swefn Pharmaceuticals Private Limited is audited by VIPUL PATEL & CO. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VIPUL PATEL & CO. | FY 2024 | 142958W |
Shareholding
The shareholding of Swefn Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Swefn Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹7.45 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Apr 2019 | 100260823 | The Kalupur Commercial Co-Operative Bank Limited | ₹7.45 Cr | Open |
To see the full charge records of Swefn Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Swefn Pharmaceuticals Private Limited has 1 deal on record (1 secondary share transfer); the latest was in February 2018.
Total deals
1
Secondary share transfer
1
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2018 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Swefn Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Total cases
1
Filed against the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Pithoragarh, Uttarakhand | Interim or miscellaneous application | Filed against the company by an individual | Disposed |
To see the full case history of Swefn Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Swefn Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Swefn Pharmaceuticals Private Limited has a workforce of 35 employees on its EPFO records as of Mar 27, 2025, across 1 active EPFO establishment.
Employee count
35
Active EPFO establishments
1
Employee growth
16.67%
GST
Swefn Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAZCS2385Q1Z8 | Gujarat | Active | 15 Feb 2018 |
To see the full GST registrations and return filing status of Swefn Pharmaceuticals Private Limited, buy the company report.
Recent activity
Swefn Pharmaceuticals Private Limited has 8 board changes on record since 2017: 6 appointments and 2 cessations. The latest: Dharmesbhai Babubhai Satashia ceased to be Additional Director on 29 Sep 2023.
AGM
Swefn Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with The Kalupur Commercial Co-Operative Bank Limited of Rs. 7.45 Cr registered on 20 Apr 2019 with Charge ID 100260823 was modified on 30 May 2025.
Filing
Swefn Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Ceased
Dharmesbhai Babubhai Satashia ceased to be Additional Director.
Ceased
Vitul Mahendrabhai Patel ceased to be Additional Director.
Appointed
Dharmesbhai Babubhai Satashia was appointed as Director.
Appointed
Vitul Mahendrabhai Patel was appointed as Director.
Charges
A charge with The Kalupur Commercial Co-Operative Bank Limited amounted to Rs. 7.45 Cr with Charge ID 100260823 was registered on 20 Apr 2019.
Appointed
Keval Kishorbhai Satasiya was appointed as Director.
Appointed
Nikunj Dineshbhai Satasiya was appointed as Director.
Appointed
Dhavalkumar Himmatbhai Satashia was appointed as Director.
Appointed
Niharbhai Sureshbhai Satasiya was appointed as Director.
1 earlier event is in the company report.
Frequently asked questions
Swefn Pharmaceuticals is an active private limited company based in Moraiya, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 September 2017 (9+ years old) and is registered under CIN U24110GJ2017PTC099133.
Swefn Pharmaceuticals has 6 current directors:
- Dhavalkumar Himmatbhai Satashia - Director
- Niharbhai Sureshbhai Satasiya - Director
- Keval Kishorbhai Satasiya - Director
- Nikunj Dineshbhai Satasiya - Director
- Dharmesbhai Babubhai Satashia - Director
- Vitul Mahendrabhai Patel - Director
The latest financial statements of Swefn Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Swefn Pharmaceuticals is 24AAZCS2385Q1Z8, registered in Gujarat.
The CIN (Corporate Identification Number) of Swefn Pharmaceuticals is U24110GJ2017PTC099133. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Swefn Pharmaceuticals has 1 court case on record: 1 filed against it.
Swefn Pharmaceuticals was incorporated on 18 September 2017, making it 9+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Swefn Pharmaceuticals has 1 deal on record (1 secondary share transfer); the latest was in February 2018.
The peers of Swefn Pharmaceuticals by revenue are Premium Serums and Vaccines Private Limited, Africure Pharmaceuticals (India) Private Limited, Pharmax India Private Limited, Merril Pharma Private Limited, Hiral Labs Limited and 2 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Dharmesbhai Babubhai Satashia ceased to be Additional Director on 29 Sep 2023. Vitul Mahendrabhai Patel ceased to be Additional Director on 29 Sep 2023. Dharmesbhai Babubhai Satashia was appointed as Director on 24 Apr 2023. Swefn Pharmaceuticals has 8 board changes on record in total.
Yes, Swefn Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-GJ-01-0000950).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages